# Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

> **NCT00775814** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 188 (actual)

## Conditions studied

- Obesity
- Hypertension

## Interventions

- **DRUG:** Candesartan and Hydrochlorothiazide
- **DRUG:** Hydrochlorothiazide (HCT)

## Key facts

- **NCT ID:** NCT00775814
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2012-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00775814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00775814, "Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00775814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*